FBXL6 and hepatocellular carcinoma: To test this possibility, we compared the half-life of HSP90AA1 in HCC cells with or without FBXL6 expression and found that the half-life of HSP90AA1 in FBXL6 KO cells was significantly reduced relative to the WT counterpart (Fig. 4f).